Business
Found 428 articles
Replimune revives melanoma drug bid after FDA leadership shift
Following the departure of former Commissioner Marty Makary, Replimune is resubmitting its melanoma treatment for FDA approval. The company confirms it has reached a new alignment with agency regulators, aiming to break a deadlock that previously stalled the experimental therapy despite vocal support from segments of the medical community.
Asian snack brands break out of the ethnic aisle
When Candice Choi launched her Korean seaweed snack brand, Geem, in 2023, she anticipated a digital-first existence defined by TikTok trends. Instead, the company bypassed the traditional retail gatekeepers, landing its chips directly alongside kale and veggie straws in mainstream grocery aisles within just three months of operation.
CVS Caremark Expands Obesity Drug Access with Zepbound Reinstatement
CVS Health will restore coverage for Eli Lilly’s weight-loss injection Zepbound and add its new pill, Foundayo, to standard pharmacy benefit plans, marking a significant shift in the competitive landscape for GLP-1 treatments.
Aerie Drives Growth as American Eagle Struggles With Brand Identity
Gap Shares Slide 14% as Old Navy Sales Miss Targets
